Magdy M. Abdel-Malik, Ph.D. Expert Witness

Contact this Expert Witness

  • Company: Quaestio Global Partners LLC
  • Phone: (908) 294-2183
  • Cell: (908) 294-2183

Specialties & Experience of this Expert Witness

General Specialties:

Pharmaceutical Research and Chemistry & Chemicals

Keywords/Search Terms:

Analytical chemistry , Drug delivery systems , Natural products chemistry, Oral cavity health, Chemicals characterization, Hair care, Smoking cessation, Cosmetic products, innovation assessment, Organic chemistry, Dietary supplements, Intellectual property (IP) , Over the counter (OTC) medicines


Ph.D., Mansoura University, Egypt; MSc, Ain Shams University, Egypt; BSc, Assiut University, Egypt

Years in Practice:


Number of Times Deposed/Testified in Last 4 Yrs:


Additional Information

SUMMARY: Dr. Abdel-Malik is an accomplished executive innovation leader with a Ph.D. in Organic/Natural Products Chemistry. His expertise lies in the intersection of R&D and business development in the life sciences, particularly in pharmaceuticals and consumer products. PHARMACEUTICALS AND CONSUMER PRODUCTS: AREAS OF EXPERTISE Dr. Abdel-Malik has developed comprehensive expertise across diverse therapeutic areas within pharmaceuticals and consumer products. This expertise includes organic chemistry; natural products chemistry; rare autoimmune diseases medicines (such as tumor necrosis factor-alpha (TNF-α)); gene delivery systems; and regenerative medicines; over-the-counter (OTC) medicines; analytical chemistry (NMR, MS, HPLC, GC, etc.); carbohydrate chemistry; polysaccharide chemistry; chemicals characterization; consumer self-care products; drug delivery systems; formulation technologies; pain management; nicotine replacement therapies; respiratory health (cough and cold; allergy; etc.); hair care products; gastrointestinal (GI) health (gut health; microbiome; etc.); oral cavity health products (mouthwash; denture cleansing; etc.); innovation assessment; development; and commercialization; intellectual properties (IP) assessment; product characterization and structure elucidation; cosmetics; dermo-cosmetics; therapeutic skincare; dietary supplements; and others. PROFESSIONAL EXPERIENCE: As the founder of a boutique management-consulting firm, Dr. Abdel-Malik specializes in guiding R&D innovation leaders in life science toward above-market growth through external innovation models. His clientele ranges from global corporations to startups in pharmaceuticals, consumer healthcare, cosmetics, nutraceuticals, and personal care industries. Established in 2007, his consultancy advises R&D clients on various topics, including R&D strategies, innovation assessment, product discovery, formulations, and commercialization. In his role as an interim executive, Dr. Abdel-Malik excels in leadership and change management, crucial for translating R&D challenges into viable business opportunities. He serves as a knowledgeable expert witness, offering diverse scientific and business insights within the life science industry, enabling evidence-based assessments, information gathering, and in-depth R&D research to establish the facts. Prior to founding his consultancy, Dr. Abdel-Malik held leadership roles in global prestigious global organizations and conducted research at renowned North American universities. He is an author and co-author of several publications and presents at global scientific and business events. He is an inventor and holds patents within the life sciences. EXPERT WITNESS COMPETENCES: Dr. Abdel-Malik is a skilled expert witness with comprehensive R&D and business knowledge within the life science industry, coupled with exceptional organizational, investigative, and research skills. He consistently exhibits confidence throughout the process of preparing expert reports, testifying in deposition and trial, and helping the jury make sense of the factual evidence in the case. Most recently, he was retained by a prestigious American multinational law firm to represent a defendant in a civil lawsuit filed in a federal circuit court. The case involves pharmaceutical formulations.